We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
DAXXIFY (Revance Australia Pty Ltd)
Product name
DAXXIFY
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
162 (255 working days)
Active ingredients
daxibotulinumtoxinA
Registration type
NCE/ NBE
Indication
DAXXIFY is indicated for:
- the temporary improvement in the appearance of moderate to severe glabellar linesassociated with corrugator and/or procerus muscle activity in adult patients.
- the treatment of cervical dystonia in adult patients.